CHAMBERLAIN UNIVERSITY NR 293 – PHARMACOLOGY
EXAM 2 | NEWEST EXAM WITH COMPLETE QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES | ALREADY GRADED A+|
|BRAND NEW VERSION!!
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Q1-Q25)
Q1. Which term describes what the BODY does to a drug?
A) Pharmacodynamics
B) Pharmacotherapeutics
C) Pharmacokinetics
D) Pharmacognosy
Correct Answer: C
Rationale: Pharmacokinetics is the study of what the body does to a drug,
specifically involving the processes of absorption, distribution, metabolism,
and excretion (ADME). Pharmacodynamics, in contrast, refers to what the drug
does to the body, such as its biochemical and physiological effects.
Q2. Which term describes what the DRUG does to the body?
A) Pharmacokinetics
B) Pharmacodynamics
C) Pharmacotherapeutics
D) Pharmacognosy
Correct Answer: B
Rationale: Pharmacodynamics is the study of what the drug does to the body—
the biochemical and physiological effects of drugs and their mechanisms of
action.
Q3. The "first-pass effect" refers to:
A) The drug being metabolized by the liver before reaching systemic circulation
B) The drug binding to plasma proteins
C) The drug being excreted by the kidneys
D) The drug crossing the blood-brain barrier
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of an oral drug by
1
,the liver before it enters the systemic circulation. This process can
significantly reduce the bioavailability of orally administered drugs.
Q4. Bioavailability is defined as:
A) The time it takes for a drug to reach its maximum therapeutic response
B) The amount of the drug that is actually available after being metabolized
C) The time it takes for a drug to elicit a therapeutic response
D) The time a drug concentration is sufficient to elicit a response
Correct Answer: B
Rationale: Bioavailability is the extent of drug absorption for a given drug
and route—the amount of active drug that reaches systemic circulation.
Q5. What is the term for the time it takes for a drug to reach its maximum
therapeutic response?
A) Onset
B) Duration
C) Peak
D) Half-life
Correct Answer: C
Rationale: Peak is the time it takes for a drug to reach its maximum
therapeutic response. Onset is the time to first response; duration is how
long the response lasts.
Q6. The time it takes for one-half of the original amount of a drug to leave
the body is called:
A) Onset
B) Peak
C) Half-life
D) Duration
Correct Answer: C
Rationale: Half-life is the time required for the serum concentration of a
drug to decrease by 50%. It helps determine appropriate dosing intervals.
Q7. A drug that binds to a receptor and produces a response is called a(n):
A) Antagonist
2
,B) Agonist
C) Enzyme
D) Inhibitor
Correct Answer: B
Rationale: An agonist is a drug that binds to a receptor and produces a
response. An antagonist binds but produces no response.
Q8. Which route of administration has the FASTEST onset of action?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
Correct Answer: D
Rationale: Intravenous administration delivers the drug directly into the
bloodstream, bypassing the absorption phase entirely and providing the most
rapid onset of action. This route is preferred in emergencies.
Q9. A patient is taking a drug that is 95% protein-bound. What is the most
likely outcome if a second highly protein-bound drug is added?
A) Decreased effect of the first drug
B) Increased free drug levels and possible toxicity
C) No significant interaction
D) Increased renal excretion of both drugs
Correct Answer: B
Rationale: When two highly protein-bound drugs are administered together,
they compete for the same binding sites on plasma proteins. This competition
displaces one drug, increasing its free (unbound) concentration, which can
lead to toxicity.
Q10. Which of the following is NOT a phase of pharmacokinetics?
A) Absorption
B) Distribution
C) Metabolism
D) Potentiation
3
, Correct Answer: D
Rationale: The four phases of pharmacokinetics are absorption, distribution,
metabolism, and excretion (ADME). Potentiation is a pharmacodynamic
interaction.
Q11. What is the primary organ responsible for drug metabolism?
A) Kidneys
B) Liver
C) Lungs
D) Intestines
Correct Answer: B
Rationale: The liver is the primary organ responsible for drug metabolism
through enzymatic processes, particularly the cytochrome P450 system.
Q12. What is the primary organ responsible for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Skin
Correct Answer: C
Rationale: The kidneys are the primary organs responsible for drug excretion,
removing drugs and their metabolites from the body through urine.
Q13. A drug that binds to a receptor but does NOT produce a response is called:
A) Agonist
B) Antagonist
C) Partial agonist
D) Inverse agonist
Correct Answer: B
Rationale: An antagonist binds to a receptor but does not produce a response.
Instead, it blocks other substances from binding to the receptor.
Q14. What is the therapeutic index?
A) The ratio of the toxic dose to the therapeutic dose
B) The time it takes for a drug to reach peak effect
4
EXAM 2 | NEWEST EXAM WITH COMPLETE QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES | ALREADY GRADED A+|
|BRAND NEW VERSION!!
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Q1-Q25)
Q1. Which term describes what the BODY does to a drug?
A) Pharmacodynamics
B) Pharmacotherapeutics
C) Pharmacokinetics
D) Pharmacognosy
Correct Answer: C
Rationale: Pharmacokinetics is the study of what the body does to a drug,
specifically involving the processes of absorption, distribution, metabolism,
and excretion (ADME). Pharmacodynamics, in contrast, refers to what the drug
does to the body, such as its biochemical and physiological effects.
Q2. Which term describes what the DRUG does to the body?
A) Pharmacokinetics
B) Pharmacodynamics
C) Pharmacotherapeutics
D) Pharmacognosy
Correct Answer: B
Rationale: Pharmacodynamics is the study of what the drug does to the body—
the biochemical and physiological effects of drugs and their mechanisms of
action.
Q3. The "first-pass effect" refers to:
A) The drug being metabolized by the liver before reaching systemic circulation
B) The drug binding to plasma proteins
C) The drug being excreted by the kidneys
D) The drug crossing the blood-brain barrier
Correct Answer: A
Rationale: The first-pass effect refers to the metabolism of an oral drug by
1
,the liver before it enters the systemic circulation. This process can
significantly reduce the bioavailability of orally administered drugs.
Q4. Bioavailability is defined as:
A) The time it takes for a drug to reach its maximum therapeutic response
B) The amount of the drug that is actually available after being metabolized
C) The time it takes for a drug to elicit a therapeutic response
D) The time a drug concentration is sufficient to elicit a response
Correct Answer: B
Rationale: Bioavailability is the extent of drug absorption for a given drug
and route—the amount of active drug that reaches systemic circulation.
Q5. What is the term for the time it takes for a drug to reach its maximum
therapeutic response?
A) Onset
B) Duration
C) Peak
D) Half-life
Correct Answer: C
Rationale: Peak is the time it takes for a drug to reach its maximum
therapeutic response. Onset is the time to first response; duration is how
long the response lasts.
Q6. The time it takes for one-half of the original amount of a drug to leave
the body is called:
A) Onset
B) Peak
C) Half-life
D) Duration
Correct Answer: C
Rationale: Half-life is the time required for the serum concentration of a
drug to decrease by 50%. It helps determine appropriate dosing intervals.
Q7. A drug that binds to a receptor and produces a response is called a(n):
A) Antagonist
2
,B) Agonist
C) Enzyme
D) Inhibitor
Correct Answer: B
Rationale: An agonist is a drug that binds to a receptor and produces a
response. An antagonist binds but produces no response.
Q8. Which route of administration has the FASTEST onset of action?
A) Oral
B) Subcutaneous
C) Intramuscular
D) Intravenous
Correct Answer: D
Rationale: Intravenous administration delivers the drug directly into the
bloodstream, bypassing the absorption phase entirely and providing the most
rapid onset of action. This route is preferred in emergencies.
Q9. A patient is taking a drug that is 95% protein-bound. What is the most
likely outcome if a second highly protein-bound drug is added?
A) Decreased effect of the first drug
B) Increased free drug levels and possible toxicity
C) No significant interaction
D) Increased renal excretion of both drugs
Correct Answer: B
Rationale: When two highly protein-bound drugs are administered together,
they compete for the same binding sites on plasma proteins. This competition
displaces one drug, increasing its free (unbound) concentration, which can
lead to toxicity.
Q10. Which of the following is NOT a phase of pharmacokinetics?
A) Absorption
B) Distribution
C) Metabolism
D) Potentiation
3
, Correct Answer: D
Rationale: The four phases of pharmacokinetics are absorption, distribution,
metabolism, and excretion (ADME). Potentiation is a pharmacodynamic
interaction.
Q11. What is the primary organ responsible for drug metabolism?
A) Kidneys
B) Liver
C) Lungs
D) Intestines
Correct Answer: B
Rationale: The liver is the primary organ responsible for drug metabolism
through enzymatic processes, particularly the cytochrome P450 system.
Q12. What is the primary organ responsible for drug excretion?
A) Liver
B) Lungs
C) Kidneys
D) Skin
Correct Answer: C
Rationale: The kidneys are the primary organs responsible for drug excretion,
removing drugs and their metabolites from the body through urine.
Q13. A drug that binds to a receptor but does NOT produce a response is called:
A) Agonist
B) Antagonist
C) Partial agonist
D) Inverse agonist
Correct Answer: B
Rationale: An antagonist binds to a receptor but does not produce a response.
Instead, it blocks other substances from binding to the receptor.
Q14. What is the therapeutic index?
A) The ratio of the toxic dose to the therapeutic dose
B) The time it takes for a drug to reach peak effect
4
